TABLE 1.
Demographic, anamnestic, clinical, and lifestyle data of patients with rosacea (n=130), of probands* (n=64) and affected relatives (n=90)
| DEMOGRPAHICS AND DISEASE CHARACTERISTICS | PATIENTS WITH ROSACEA (N=130) | PROBANDS (N=64) | RELATIVES WITH ROSACEA (N=90) |
|---|---|---|---|
| Sex (n) | F93/M37 | F43/M21 | F56/M34 |
| Age (mean, yrs) | 49.3±16.5 | 49.6±18.6 | 52.3±18.5 |
| Skin phototype, n (F/M) | |||
| Phototype I | 14 (F9/M5) | 7 (F4/M3) | 13(F8/M5) |
| Phototype II | 69 (F56/M13) | 33 (F26/M7) | 45 (F31/M14) |
| Phototype III | 40 (F27/M13) | 20 (F12/M8) | 25 (F14/M11) |
| Phototype IV | 7 (F1/M6) | 4 (F1/M3) | 7 (F3/M4) |
| Body Mass Index, n (F/M) | |||
| Normal weight | 85 (F57/M28) | 45 (F29/M16) | 57 (F35/M22) |
| Underweight | 7 (F6/M1) | 3 (F2/M1) | 6 (F5/M1) |
| Overweight | 38 (F30/M8) | 16 (F12/M4) | 27 (F16/M11) |
| Smokers | 32 (F14/M18) | 13 (F5/M8) | -- |
| Drinkers | 9 (F4/M5) | 8 (F3/M5) | 12 (F3/M9) |
| Positive family history | 64 (F43/M21) | 64 (F43/M21) | 90 (F56/M34) |
| Disease duration | 9.7±11 | 9.8±10.6 | 12.3±13.4 |
| Phenotype of rosacea, n (F/M) | |||
| Centrofacial erythema +/- telangiectasias | 49 (F36/M13) | 26 (F18/M8) | 45 (F28/M17) |
| Centrofacial erythema +/- telangiectasias + papules and pustules | 67 (F55/M12) | 28 (F23/M5) | 32 (F26/M6) |
| Phymatous changes | 5 (M5) | 1 (M1) | 3 (M3) |
| Ocular manifestations | 9 (F2/M7) | 9 (F2/M7) | 10 (F2/M8) |
| Disease Severity, n (F/M) | |||
| Mild | 45 (F37/M8) | 21 (F18//M3) | 39 (F27//M12) |
| Moderate | 70 (F45/M25) | 35 (F21/M14) | 42 (F25/M17) |
| Severe | 15 (F11/M 4) | 8 (F4/M 4) | 9 (F4/M5) |
* Rosacea patient reporting at least one affected relative M: Male; F: Female